De Giorgi Riccardo, Series Hugh
Department of Psychiatry, University of Oxford, Warneford Lane, Oxford, OX3 7JX, UK.
Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, OX3 7JX, UK.
Curr Treat Options Neurol. 2016 Sep;18(9):41. doi: 10.1007/s11940-016-0425-2.
Inappropriate sexual behavior (ISB) is a relatively common and potentially disruptive form of behavior in people with dementia. It can cause considerable distress and put placements and people at risk. Yet it is poorly researched and understood. In addition to non-pharmacological approaches to management, a wide range of classes of medication has been used in ISB, and the results have been reported as single cases or short series, though none has been the subject of a randomized clinical trial, in part because of the lack of a well-defined method of observing and measuring ISB, as well as the significant ethical considerations. Pharmacological treatments for which there is low-level evidence of efficacy in the literature include antidepressants, antipsychotics, anticonvulsants, cholinesterase inhibitors, hormonal agents, and beta-blockers. None of the drugs discussed here is licensed for use in ISB, and elderly people, particularly those with dementia, are at high risk of adverse effects. Caution is advised before using medication in this group of people. It is important to consider alternative non-pharmacological treatments, as well as discussing issues of ethics and consent with those involved, before initiating treatment. It is helpful to identify and monitor target symptoms. Pharmacological treatments should be started at low dose and titrated up slowly and carefully. Nevertheless, in some situations, medication may provide a useful part of a management plan for ISB.
不当性行为(ISB)在痴呆症患者中是一种相对常见且可能具有破坏性的行为形式。它会导致相当大的痛苦,并使安置机构和人员面临风险。然而,对此研究和了解都很少。除了非药物管理方法外,多种类别的药物已被用于治疗ISB,其结果仅作为单个病例或短系列报道,尽管尚无一项成为随机临床试验的主题,部分原因是缺乏明确的观察和测量ISB的方法,以及重大的伦理考量。文献中有低水平疗效证据的药物治疗包括抗抑郁药、抗精神病药、抗惊厥药、胆碱酯酶抑制剂、激素制剂和β受体阻滞剂。此处讨论的药物均未获许可用于治疗ISB,老年人,尤其是患有痴呆症的老年人,不良反应风险很高。在这组人群中使用药物前建议谨慎。在开始治疗前,考虑替代的非药物治疗方法,以及与相关人员讨论伦理和同意问题很重要。识别和监测目标症状会有帮助。药物治疗应从低剂量开始,并缓慢、谨慎地滴定增加剂量。尽管如此,在某些情况下,药物可能是ISB管理计划的有益组成部分。